Results for “ ”

Entry Author Date Location
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M 05/24/19 National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Nektar Forms New Company Inheris to Take Reins on Pain, CNS Drugs 05/23/19 San Francisco
Agrilyst Rebrands as Artemis, Lands $8M for Indoor Farming Software 05/22/19 New York
With $120M, AlloVir Faces Big Test of Cell Therapy to Fight Infection 05/22/19 Texas
AI Startup Clinc Snags $52M Series B to Expand Offices, Markets 05/21/19 Detroit Ann Arbor
Sebastian Thrun and Udacity Launch New Self-Driving Nanodegree 05/21/19 San Francisco
Merck Preempts Peloton Therapeutics IPO With $1B Acquisition Deal 05/21/19 New York
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms 05/20/19 New York
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight 05/16/19 National
BioClarity, Maker of “Clean, Green” Skincare Products, Raises $13M 05/16/19 San Diego
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September 05/16/19 Boston
Karat Gets $28M for Software, Team That Assess Job-Seeking Engineers 05/15/19 Seattle
Endpoint Security Company CrowdStrike Files Publicly for IPO 05/14/19 San Francisco
ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups 05/13/19 Boston
Milestones of Innovation 17: ‘Golden Spike’ Heralds Era of Cheap Steel 05/10/19 National
Tech Ethics, Regulation & Strategy: Here’s the Napa Summit Agenda 05/10/19 National
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Uber Completes $8.1B Public Market Debut in Spite of Tumultuous Past 05/09/19 San Francisco
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials 05/09/19 National
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
Flexe Gets $43M to Expand On-demand Warehousing and Fulfillment Tools 05/07/19 Seattle
Canadian VCs Lead US in Gender Parity, But Both Need Work: Report 05/07/19 National
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea 05/06/19 New York
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More 05/03/19 National
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments 05/03/19 National
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan 05/02/19 Texas
Beyond Meat’s IPO Bags $241M to Make Plant-Based Burgers Mainstream 05/02/19 National
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease? 05/02/19 National
Page 1 of 286 next page »